BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36919607)

  • 1. An investigation of the etiology and follow-up findings in 35 children with overgrowth syndromes, including biallelic SUZ12 variant.
    Yüksel Ülker A; Uludağ Alkaya D; Çağlayan AO; Usluer E; Aykut A; Aslanger A; Vural M; Tüysüz B
    Am J Med Genet A; 2023 Jun; 191(6):1530-1545. PubMed ID: 36919607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
    Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
    Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of disorders with overgrowth and intellectual disability: Experience from a center in North India.
    Moirangthem A; Mandal K; Saxena D; Srivastava P; Gambhir PS; Agrawal N; Shambhavi A; Nampoothiri S; Phadke SR
    Am J Med Genet A; 2021 Aug; 185(8):2345-2355. PubMed ID: 33942996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.
    Imagawa E; Seyama R; Aoi H; Uchiyama Y; Marcarini BG; Furquim I; Honjo RS; Bertola DR; Kim CA; Matsumoto N
    Clin Genet; 2023 Apr; 103(4):383-391. PubMed ID: 36645289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy and overgrowth-intellectual disability syndromes: a patient organization perspective on collaborating to accelerate pathways to treatment.
    Grens K; Church KM; Diehl E; Hunter SE; Tatton-Brown K; Kiernan J; Delagrammatikas CG
    Ther Adv Rare Dis; 2024; 5():26330040241254123. PubMed ID: 38827639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation in FIBP gene.
    Akawi N; Ben-Salem S; Lahti L; Partanen J; Ali BR; Al-Gazali L
    Am J Med Genet A; 2016 Aug; 170(8):2111-8. PubMed ID: 27183861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotype of Sotos syndrome in adulthood: A review of 44 individuals.
    Foster A; Zachariou A; Loveday C; Ashraf T; Blair E; Clayton-Smith J; Dorkins H; Fryer A; Gener B; Goudie D; Henderson A; Irving M; Joss S; Keeley V; Lahiri N; Lynch SA; Mansour S; McCann E; Morton J; Motton N; Murray A; Riches K; Shears D; Stark Z; Thompson E; Vogt J; Wright M; Cole T; Tatton-Brown K
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):502-508. PubMed ID: 31479583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
    Cyrus S; Burkardt D; Weaver DD; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare SUZ12 variants commonly cause an overgrowth phenotype.
    Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty.
    Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T
    Am J Med Genet A; 2024 May; ():e63726. PubMed ID: 38814056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal Anomalies Associated with Novel Pathogenic Variants in TMEM94.
    Al-Hamed MH; Alsahan N; Tulbah M; Kurdi W; Ali W; Sayer JA; Imtiaz F
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32825426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth pattern of Rahman syndrome.
    Takenouchi T; Uehara T; Kosaki K; Mizuno S
    Am J Med Genet A; 2018 Mar; 176(3):712-714. PubMed ID: 29383847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
    Choufani S; Gibson WT; Turinsky AL; Chung BHY; Wang T; Garg K; Vitriolo A; Cohen ASA; Cyrus S; Goodman S; Chater-Diehl E; Brzezinski J; Brudno M; Ming LH; White SM; Lynch SA; Clericuzio C; Temple IK; Flinter F; McConnell V; Cushing T; Bird LM; Splitt M; Kerr B; Scherer SW; Machado J; Imagawa E; Okamoto N; Matsumoto N; Testa G; Iascone M; Tenconi R; Caluseriu O; Mendoza-Londono R; Chitayat D; Cytrynbaum C; Tatton-Brown K; Weksberg R
    Am J Hum Genet; 2020 May; 106(5):596-610. PubMed ID: 32243864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.
    Griffiths S; Loveday C; Zachariou A; Behan LA; Chandler K; Cole T; D'Arrigo S; Dieckmann A; Foster A; Gibney J; Hunter M; Milani D; Pantaleoni C; Roche E; Sherlock M; Springer A; White SM; ; Tatton-Brown K
    Am J Med Genet A; 2019 Apr; 179(4):588-594. PubMed ID: 30793471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year follow-up of the facial phenotype of Brazilian patients with Sotos syndrome.
    Castro MAA; Dos Santos JHV; Honjo RS; Yamamoto GL; Bertola DR; Hurst AC; Chorich LP; Layman LC; Kim CA; Kim HG
    Am J Med Genet A; 2021 Dec; 185(12):3916-3923. PubMed ID: 34405946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Null variants and deletions in BRWD3 cause an X-linked syndrome of mild-moderate intellectual disability, macrocephaly, and obesity: A series of 17 patients.
    Ostrowski PJ; Zachariou A; Loveday C; Baralle D; Blair E; Douzgou S; Field M; Foster A; Kyle C; Lachlan K; Mansour S; Naik S; Rea G; Smithson S; Sznajer Y; Thompson E; Cole T; Tatton-Brown K
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):638-643. PubMed ID: 31714006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.